Quoin Pharmaceuticals Reports Director & Officer Changes
Ticker: QNRX · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance, officer-appointment, director-election
TL;DR
Quoin Pharma (QNRX) filing shows board/exec changes effective 5/29.
AI Summary
Quoin Pharmaceuticals, Ltd. filed an 8-K on June 4, 2025, reporting changes effective May 29, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. The company was formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future company direction and performance.
Key Players & Entities
- Quoin Pharmaceuticals, Ltd. (company) — Filer
- Cellect Biotechnology Ltd. (company) — Former Company Name
- Cellect Biomed Ltd. (company) — Former Company Name
- May 29, 2025 (date) — Effective Date of Reported Events
- June 4, 2025 (date) — Filing Date
FAQ
What specific roles were affected by the director and officer changes?
The filing indicates changes related to the departure of directors or certain officers, election of directors, and appointment of certain officers, but does not specify the exact roles in the provided text.
Were there any new compensatory arrangements disclosed for officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure, suggesting such arrangements may be detailed within the full document.
When were the reported changes effective?
The earliest event reported was effective May 29, 2025.
What is Quoin Pharmaceuticals' former name?
Quoin Pharmaceuticals, Ltd. was formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd.
What is the primary business of Quoin Pharmaceuticals?
Quoin Pharmaceuticals, Ltd. is in the Pharmaceutical Preparations industry, SIC code 2834.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).